Matches in Nanopublications for { ?s ?p "[The favorable outcome associated with FCGR2A (R/R) genotype is consistent with the proposed role of FCGR2A and phagocyte-mediated ADCC in 3F8 plus GM-CSF immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP64545.RARQDueuzuhqimpB3W5E7cYOW_bul0zGcfubGSTMyHLkM130_assertion description "[The favorable outcome associated with FCGR2A (R/R) genotype is consistent with the proposed role of FCGR2A and phagocyte-mediated ADCC in 3F8 plus GM-CSF immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64545.RARQDueuzuhqimpB3W5E7cYOW_bul0zGcfubGSTMyHLkM130_provenance.
- NP64555.RALBCV22glTf-5MuFojbbPQagM_7Zh9ROV6kagIxsz20g130_assertion description "[The favorable outcome associated with FCGR2A (R/R) genotype is consistent with the proposed role of FCGR2A and phagocyte-mediated ADCC in 3F8 plus GM-CSF immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64555.RALBCV22glTf-5MuFojbbPQagM_7Zh9ROV6kagIxsz20g130_provenance.
- NP918177.RAeYAU_nGVUgy2wiG75Sb7WWKYQso_rlkoiJZGHwvwaMY130_assertion description "[The favorable outcome associated with FCGR2A (R/R) genotype is consistent with the proposed role of FCGR2A and phagocyte-mediated ADCC in 3F8 plus GM-CSF immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP918177.RAeYAU_nGVUgy2wiG75Sb7WWKYQso_rlkoiJZGHwvwaMY130_provenance.
- assertion description "[The favorable outcome associated with FCGR2A (R/R) genotype is consistent with the proposed role of FCGR2A and phagocyte-mediated ADCC in 3F8 plus GM-CSF immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The favorable outcome associated with FCGR2A (R/R) genotype is consistent with the proposed role of FCGR2A and phagocyte-mediated ADCC in 3F8 plus GM-CSF immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP83604.RAWtejJlvyyHZihZ6GN3e7Fa7B-5tACGTCkUM_DGaFwcE130_assertion description "[The favorable outcome associated with FCGR2A (R/R) genotype is consistent with the proposed role of FCGR2A and phagocyte-mediated ADCC in 3F8 plus GM-CSF immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83604.RAWtejJlvyyHZihZ6GN3e7Fa7B-5tACGTCkUM_DGaFwcE130_provenance.
- NP83614.RAYsPLzrpCJySNwxdgTi-1ssTg1vDI9EaGCaZLAqr9HUA130_assertion description "[The favorable outcome associated with FCGR2A (R/R) genotype is consistent with the proposed role of FCGR2A and phagocyte-mediated ADCC in 3F8 plus GM-CSF immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83614.RAYsPLzrpCJySNwxdgTi-1ssTg1vDI9EaGCaZLAqr9HUA130_provenance.
- NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_assertion description "[The favorable outcome associated with FCGR2A (R/R) genotype is consistent with the proposed role of FCGR2A and phagocyte-mediated ADCC in 3F8 plus GM-CSF immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100487.RAU5hhTCgUzsFoASFz5KXlrnPLvjamLI6lcQxZHKuz_14130_provenance.
- NP100486.RAxqPGHsjy-NvCC_2jzuxHkbFLRMm_mCC1GjxaykvqUTU130_assertion description "[The favorable outcome associated with FCGR2A (R/R) genotype is consistent with the proposed role of FCGR2A and phagocyte-mediated ADCC in 3F8 plus GM-CSF immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100486.RAxqPGHsjy-NvCC_2jzuxHkbFLRMm_mCC1GjxaykvqUTU130_provenance.